Psychiatric Quarterly, Vol. 75, No. 4, Winter 2004 (
DEPRESSION, ANXIETY, ANGER, AND
SOMATIC SYMPTOMS IN PATIENTS WITH
BODY DYSMORPHIC DISORDER
Katharine A. Phillips, M.D., Jason M. Siniscalchi, M.S.,
and Susan L. McElroy, M.D.
Body dysmorphic disorder (BDD) is a relatively common and impairing dis-
order. However, little is known about non-BDD symptoms and well-being in
patients with this disorder. Seventy-ﬁve outpatients with DSM-IV BDD com-
pleted the Symptom Questionnaire, a validated self-report measure with four
scales: depression, anxiety, somatic/somatization, and anger-hostility. Scores
were compared to published norms for normal subjects and psychiatric outpa-
tients. Participants in an open-label ﬂuvoxamine trial completed the Symptom
Questionnaire at baseline and endpoint. Compared to normal controls, BDD
subjects had markedly elevated scores on all four scales, indicating severe dis-
tress and psychopathology. Compared to psychiatric patients, BDD subjects
had higher scores on the depression, anxiety, and anger/hostility scales but not
on the somatic/somatization scale. Scores on all scales signiﬁcantly decreased
with ﬂuvoxamine. In conclusion, patients with BDD have markedly high levels
of distress, are highly symptomatic, and have poor well-being in the domains of
Katharine A. Phillips, M.D., is afﬁliated with Department of Psychiatry and Human
Behavior, Brown Medical School, Butler Hospital, Providence, RI.
Jason M. Siniscalchi, M.S., is afﬁliated with Butler Hospital, Providence, RI.
Susan L. McElroy, M.D., is afﬁliated with University of Cincinnati School of Medicine,
Address correspondence to Katharine A. Phillips, M.D., Butler Hospital, 345 Blackstone
Boulevard, Providence, RI 02906; e-mail: katharine
2004 Springer Science+Business Media, Inc.